{"target": {"tractability": {"smallmolecule": {"top_category": "Clinical_Precedence", "small_molecule_genome_member": true, "buckets": [1, 4, 5, 7, 8], "high_quality_compounds": 0, "ensemble": 0.79167199, "categories": {"clinical_precedence": 1.0, "predicted_tractable": 1.0, "discovery_precedence": 1.0}}, "antibody": {"top_category": "Predicted_Tractable__Medium_to_low_confidence", "buckets": [8], "categories": {"predicted_tractable_med_low_confidence": 0.25, "clinical_precedence": 0.0, "predicted_tractable_high_confidence": 0.0}}}, "gene_info": {"symbol": "PIK3CA", "name": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"}, "id": "ENSG00000121879"}, "association_score": {"datatypes": {"literature": 0.32554481814270364, "rna_expression": 0.0, "genetic_association": 1.0, "somatic_mutation": 1.0, "known_drug": 1.0, "animal_model": 0.18888000000000002, "affected_pathway": 1.0}, "overall": 1.0, "datasources": {"progeny": 0.724214062011764, "sysbio": 0.0, "expression_atlas": 0.0, "europepmc": 0.32554481814270364, "intogen": 0.6647207960748707, "phewas_catalog": 0.0, "uniprot_literature": 1, "phenodigm": 0.18888000000000002, "eva": 1, "gene2phenotype": 1, "gwas_catalog": 0.0, "slapenrich": 0.8174919500924461, "genomics_england": 1, "postgap": 0.0, "uniprot": 1, "chembl": 1, "cancer_gene_census": 0.9067988983318935, "reactome": 1, "uniprot_somatic": 0.8682924638231565, "eva_somatic": 0.9083243889916071, "crispr": 0.983372489229025}}, "disease": {"efo_info": {"therapeutic_area": {"labels": ["neoplastic, precancerous and hyperplastic disease"], "codes": ["MONDO_0045024"]}, "path": [["MONDO_0045024"]], "label": "neoplastic, precancerous and hyperplastic disease"}, "id": "MONDO_0045024"}, "is_direct": false, "evidence_count": {"datatypes": {"literature": 7274.0, "rna_expression": 0.0, "genetic_association": 91.0, "somatic_mutation": 1216.0, "known_drug": 261.0, "animal_model": 1.0, "affected_pathway": 534.0}, "total": 9377.0, "datasources": {"progeny": 11.0, "sysbio": 0.0, "expression_atlas": 0.0, "europepmc": 7274.0, "intogen": 20.0, "phewas_catalog": 0.0, "uniprot_literature": 7.0, "phenodigm": 1.0, "eva": 30.0, "gene2phenotype": 2.0, "gwas_catalog": 0.0, "slapenrich": 480.0, "genomics_england": 6.0, "postgap": 0.0, "uniprot": 46.0, "chembl": 261.0, "cancer_gene_census": 471.0, "reactome": 36.0, "uniprot_somatic": 21.0, "eva_somatic": 704.0, "crispr": 7.0}}, "id": "ENSG00000121879-MONDO_0045024"}
{"target": {"tractability": {"smallmolecule": {"top_category": "Clinical_Precedence", "small_molecule_genome_member": true, "buckets": [1, 4, 5, 7, 8], "high_quality_compounds": 0, "ensemble": 0.79167199, "categories": {"clinical_precedence": 1.0, "predicted_tractable": 1.0, "discovery_precedence": 1.0}}, "antibody": {"top_category": "Predicted_Tractable__Medium_to_low_confidence", "buckets": [8], "categories": {"predicted_tractable_med_low_confidence": 0.25, "clinical_precedence": 0.0, "predicted_tractable_high_confidence": 0.0}}}, "gene_info": {"symbol": "PIK3CA", "name": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"}, "id": "ENSG00000121879"}, "association_score": {"datatypes": {"literature": 0.32554481814270364, "rna_expression": 0.0, "genetic_association": 1.0, "somatic_mutation": 1.0, "known_drug": 1.0, "animal_model": 0.18888000000000002, "affected_pathway": 1.0}, "overall": 1.0, "datasources": {"progeny": 0.724214062011764, "sysbio": 0.0, "expression_atlas": 0.0, "europepmc": 0.32554481814270364, "intogen": 0.6647207960748707, "phewas_catalog": 0.0, "uniprot_literature": 1, "phenodigm": 0.18888000000000002, "eva": 1, "gene2phenotype": 1, "gwas_catalog": 0.0, "slapenrich": 0.8174919500924461, "genomics_england": 1, "postgap": 0.0, "uniprot": 1, "chembl": 1, "cancer_gene_census": 0.9067988983318935, "reactome": 1, "uniprot_somatic": 0.8682924638231565, "eva_somatic": 0.9083243889916071, "crispr": 0.983372489229025}}, "disease": {"efo_info": {"therapeutic_area": {"labels": ["neoplastic, precancerous and hyperplastic disease"], "codes": ["MONDO_0045024"]}, "path": [["MONDO_0045024", "MONDO_0023370"]], "label": "neoplastic disease or syndrome"}, "id": "MONDO_0023370"}, "is_direct": false, "evidence_count": {"datatypes": {"literature": 7249.0, "rna_expression": 0.0, "genetic_association": 91.0, "somatic_mutation": 1216.0, "known_drug": 261.0, "animal_model": 1.0, "affected_pathway": 534.0}, "total": 9352.0, "datasources": {"progeny": 11.0, "sysbio": 0.0, "expression_atlas": 0.0, "europepmc": 7249.0, "intogen": 20.0, "phewas_catalog": 0.0, "uniprot_literature": 7.0, "phenodigm": 1.0, "eva": 30.0, "gene2phenotype": 2.0, "gwas_catalog": 0.0, "slapenrich": 480.0, "genomics_england": 6.0, "postgap": 0.0, "uniprot": 46.0, "chembl": 261.0, "cancer_gene_census": 471.0, "reactome": 36.0, "uniprot_somatic": 21.0, "eva_somatic": 704.0, "crispr": 7.0}}, "id": "ENSG00000121879-MONDO_0023370"}
{"target": {"tractability": {"smallmolecule": {"top_category": "Clinical_Precedence", "small_molecule_genome_member": true, "buckets": [1, 4, 5, 7, 8], "high_quality_compounds": 0, "ensemble": 0.79167199, "categories": {"clinical_precedence": 1.0, "predicted_tractable": 1.0, "discovery_precedence": 1.0}}, "antibody": {"top_category": "Predicted_Tractable__Medium_to_low_confidence", "buckets": [8], "categories": {"predicted_tractable_med_low_confidence": 0.25, "clinical_precedence": 0.0, "predicted_tractable_high_confidence": 0.0}}}, "gene_info": {"symbol": "PIK3CA", "name": "phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha"}, "id": "ENSG00000121879"}, "association_score": {"datatypes": {"literature": 0.32554481814270364, "rna_expression": 0.0, "genetic_association": 1.0, "somatic_mutation": 1.0, "known_drug": 1.0, "animal_model": 0.0, "affected_pathway": 1.0}, "overall": 1.0, "datasources": {"progeny": 0.724214062011764, "sysbio": 0.0, "expression_atlas": 0.0, "europepmc": 0.32554481814270364, "intogen": 0.6647207960748707, "phewas_catalog": 0.0, "uniprot_literature": 1, "phenodigm": 0.0, "eva": 1, "gene2phenotype": 1.0, "gwas_catalog": 0.0, "slapenrich": 0.8174919500924461, "genomics_england": 1, "postgap": 0.0, "uniprot": 1, "chembl": 1, "cancer_gene_census": 0.9067988983318935, "reactome": 1, "uniprot_somatic": 0.8682924638231565, "eva_somatic": 0.9083243889916071, "crispr": 0.983372489229025}}, "disease": {"efo_info": {"therapeutic_area": {"labels": ["neoplastic, precancerous and hyperplastic disease"], "codes": ["MONDO_0045024"]}, "path": [["MONDO_0045024", "MONDO_0023370", "EFO_0000616"]], "label": "neoplasm"}, "id": "EFO_0000616"}, "is_direct": true, "evidence_count": {"datatypes": {"literature": 7225.0, "rna_expression": 0.0, "genetic_association": 68.0, "somatic_mutation": 1212.0, "known_drug": 261.0, "animal_model": 0.0, "affected_pathway": 534.0}, "total": 9300.0, "datasources": {"progeny": 11.0, "sysbio": 0.0, "expression_atlas": 0.0, "europepmc": 7225.0, "intogen": 20.0, "phewas_catalog": 0.0, "uniprot_literature": 6.0, "phenodigm": 0.0, "eva": 27.0, "gene2phenotype": 1.0, "gwas_catalog": 0.0, "slapenrich": 480.0, "genomics_england": 2.0, "postgap": 0.0, "uniprot": 32.0, "chembl": 261.0, "cancer_gene_census": 471.0, "reactome": 36.0, "uniprot_somatic": 21.0, "eva_somatic": 700.0, "crispr": 7.0}}, "id": "ENSG00000121879-EFO_0000616"}
